EnWave Corporation · TSXV:ENW
EnWave — Investor Presentation (February 2012)
19 slides from EnWave's investor presentation, February 2012
Slide 1: Revolutionary Dehydration Technology
Revolutionary Dehydration Technology Global research collaborator with Nestlé, Grupo Bimbo, Kellogg, Grimmway Farms, Bonduelle, Ocean Spray, Hormel & Merck
Slide 2: Company
Company Radiant Energy Vacuum (“REV”) Dehydration Technology Vancouver-based industrial technology company, University of British Columbia spin-off REV is a new proprietary method of drying a diverse range of materials for very large global markets
Slide 3: Market
Market Globally diversified market opportunity $140 Potential market for REV dehydration as a replacement for $31 freeze, air and spray drying estimated at USD$ 400bn* $92 $61 $4 $5 $67 * Source: company data and industry reports. Data represents potential targets for REV. There is no guarantee EnWa
Slide 4: Method
Method Radiant Energy Vacuum (“REV”) Method Process Economics Product Quality Spray & Air Drying High heat using hot air into a Low cost Heat & oxygen damage chamber or on continuous belt High speed nutrients, flavour, colour, texture, bioactivity Freeze Drying Freeze and slowly remove Very slow Hig
Slide 5: Market Position
Market Position Targeted REV Advantages* Replace freeze drying as the new industry standard for drying sensitive, high-value food & biological materials: Cheaper – up to 80% lower processing costs Faster – process in minutes or hours vs. days Smaller – seamless integration, smaller footprint
Slide 6: Business Strategy
Business Strategy Two tiers for broader market acceptance EnWave intends to build a royalty stream from technology licenses and outsource REV machine manufacturing Tier One: Strategic collaborations with leading multinationals, exclusive agreements for specific market segments, targeted annual royal
Slide 7: Major Recent Achievements
Major Recent Achievements Public Markets Growth Technology and Facility Progress I.P Acquisitions and Trademarks First Major Commercial Agreement (Milne Fruit Products) First Major Pharmaceutical Agreement (Merck) Multinational Collaborations Expanded
Slide 8: Public Markets Growth
Public Markets Growth Raised more than $20 million in equity & grants ENW 5 Year Stock Chart Substantial market capitalization increase Institutional shareholder base expanded in Europe, Canada & the U.S. Share liquidity in Canada & Germany improved
Slide 9: Technology & Facility Progress
Technology & Facility Progress Pilot Plant Opened, Engineering Facilities Doubled Platforms Expanded Functionality Markets nutraREV™ Dehydrates pieces of solid Low-fat snacks Functional foods food; continuous tumble Nutraceuticals Dried fruits, drying Pet food vegetables, herbs Baby food meats powde
Slide 10: I.P. Acquisitions and Trademarks
I.P. Acquisitions and Trademarks Acquired US patents & know-how from German competitor Hans Binder for CDN$1.5M ($550,000 cash plus 550,000 shares), obtained share of royalties from future MIVAP™ licenses Exclusive North American and non-exclusive global marketing rights for MIVAP™ technology, long-
Slide 11: First Major Commercial Agreement
First Major Commercial Agreement Milne Fruit is a leading US fruit supplier operating since the 1950’s Highly respected supplier of quality fresh fruit, juices & purees Commercial royalty bearing licence signed with EnWave May 2011 includes dried natural fruit snacks and powders MIVAP™ plant to be d
Slide 12: First Major Commercial Agreement
First Major Commercial Agreement Competitive freeze dried fruits lack colour, texture, flavour and in many cases processed in China Milne “Made in America” launch includes food brokers covering over 90% of U.S. States, Ontario & Quebec First plant in Idaho capable of expanding to multiple machines A
Slide 13: First Major Pharma Agreement
First Major Pharma Agreement Independent testing of single-vial freezeREV™ machine demonstrated the significant reduction in drying times of vaccines and antibodies from over 40hrs to less than 50 minutes Successful scale-up from single-vial to 250 multi-vial/bulk powder Signed Research Evaluation A
Slide 14: Collaborations and Customers
Collaborations and Customers Gaining momentum Enquiries from more than 150 interested customers Top 40+ signed confidentiality agreements; focus on top 15 to 20 Collaborations announced as of February 2012: 2010 2011 Nestlé Kellogg Co. Grupo Bimbo Bonduelle Grimmway Farms Ocean Spray Hormel Foods Me
Slide 15: Multinational Collaborations
Multinational Collaborations Global Size Product Agreement REV Licence Company Collaboration Goal ($US) Category Signed Technology Target Improvements & New Nestlé $110bn Food July 2010 nutraREV™ 2012 Brands Improvements & New Grupo Bimbo $14bn Snacks & Baking Oct. 2010 nutraREV™ 2012 Brands Cereal
Slide 16: Capital Structure
Capital Structure As of February 2012 Financial Overview: Type of Security Total Shares Outstanding 26 employees Common Shares 72,305,776 $10.5M cash, no debt Warrants 4,023,600 $200,000 current Options 4,574,000 monthly burn rate Market Cap CDN $110M $2.15M current capital & prototype projects TOTA
Slide 17: Investment Highlights
Investment Highlights Continuous valuation improvement Growing world class collaborations provide industry credibility, risk diversification and the opportunity for broader intra-company adoption Three multinational collaborations targeted for completion into commercial licences in 2012 Milne commer
Slide 18: Management
Management Building the company Dr. Tim Durance, Chairman & Co-CEO Inventor & company founder, Professor Food Science UBC John McNicol, President & Co-CEO President & COO of Concert Industries & Merfin International Bino Anand, Executive VP Sales Thirty years experience in international business Sal
Slide 19: Contact Details
Contact Details John McNicol Brent Charleton President & Co-CEO Director of Marketing & Corporate Affairs Phone: (604) 601-8524 Cell: (604) 603-2959 Cell: (778) 378-9616 Email: john.mcnicol@enwave.net Email: bcharleton@enwave.net www.enwave.net | TSX-V: ENW | FSE: E4U